• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > LMB In The News > FORMA therapeutics and Cancer Research Technology to discover cancer drugs targeting deubiquitinating enzymes (DUBs)

FORMA therapeutics and Cancer Research Technology to discover cancer drugs targeting deubiquitinating enzymes (DUBs)

Published on 10 July, 2013

LMB’s David Komander is part of collaborative consortium including FORMA Therapeutics and Cancer Research Technology, aiming to discover cancer drugs targeting deubiquitinating enzymes (DUBs). More…

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us